Cargando…

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent

Recently, we characterized neoamphimedine (neo) as an ATP-competitive inhibitor of the ATPase domain of human Topoisomerase IIα. Thus far, neo is the only pyridoacridine with this mechanism of action. One limiting factor in the development of neo as a therapeutic agent has been access to sufficient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Linfeng, Abraham, Adedoyin D., Zhou, Qiong, Ali, Hadi, O’Brien, Jeremy V., Hamill, Brayden D., Arcaroli, John J., Messersmith, Wells A., LaBarbera, Daniel V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178486/ https://www.ncbi.nlm.nih.gov/pubmed/25244109 http://dx.doi.org/10.3390/md12094833

Ejemplares similares

Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition
por: Ponder, Jessica, et al.
Publicado: (2011)

Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer
por: Zhou, Q, et al.
Publicado: (2016)

Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue
por: Chène, Patrick, et al.
Publicado: (2009)

Study of Structure–Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents
por: Zhidkov, Maxim E., et al.
Publicado: (2022)

Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri
por: Bashyal, Bharat, et al.
Publicado: (2017)

Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer
por: Esquer, Hector, et al.
Publicado: (2021)

Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment
por: Huang, Liangqun, et al.
Publicado: (2019)

DNA topoisomerases as molecular targets for anticancer drugs
por: Buzun, Kamila, et al.
Publicado: (2020)

ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism
por: Sengupta, Souvik, et al.
Publicado: (2011)

Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents
por: Liu, Yu, et al.
Publicado: (2016)

Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases
por: Jain, Chetan Kumar, et al.
Publicado: (2017)

Competitive binding of MatP and topoisomerase IV to the MukB hinge domain
por: Fisher, Gemma LM, et al.
Publicado: (2021)

Antiproliferative activities of Amaryllidaceae alkaloids from Lycoris radiata targeting DNA topoisomerase I
por: Chen, Gui-Lin, et al.
Publicado: (2016)

Boldine-Derived Alkaloids Inhibit the Activity of DNA Topoisomerase I and Growth of Mycobacterium tuberculosis
por: García, María T., et al.
Publicado: (2018)

The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants
por: Inoue, Naomi, et al.
Publicado: (2021)

Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II
por: Molinaro, Caroline, et al.
Publicado: (2020)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

Anticancer Alkaloid Lamellarins Inhibit Protein Kinases
por: Baunbæk, Dianne, et al.
Publicado: (2008)

Anticancer Alkaloids from Trees: Development into Drugs
por: Isah, Tasiu
Publicado: (2016)

Engineering biosynthesis of the anticancer alkaloid noscapine in yeast
por: Li, Yanran, et al.
Publicado: (2016)

The Anticancer Effect of Natural Plant Alkaloid Isoquinolines
por: Yun, Dahye, et al.
Publicado: (2021)

Tropinone-Derived Alkaloids as Potent Anticancer Agents: Synthesis, Tyrosinase Inhibition, Mechanism of Action, DFT Calculation, and Molecular Docking Studies
por: Piechowska, Katarzyna, et al.
Publicado: (2020)

Voreloxin Is an Anticancer Quinolone Derivative that Intercalates DNA and Poisons Topoisomerase II
por: Hawtin, Rachael E., et al.
Publicado: (2010)

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents
por: Cincinelli, Raffaella, et al.
Publicado: (2018)

Occipital intermittent rhythmic delta activity (OIRDA) in pediatric focal epilepsies: A case series
por: LaBarbera, Vincent, et al.
Publicado: (2021)

The ATP-dependent chromatin remodelling enzyme Uls1 prevents Topoisomerase II poisoning
por: Swanston, Amy, et al.
Publicado: (2019)

Catalytic Mechanism of ATP Hydrolysis in the ATPase Domain of Human DNA Topoisomerase IIα
por: Ogrizek, Mitja, et al.
Publicado: (2022)

Alkaloids Isolated from Natural Herbs as the Anticancer Agents
por: Lu, Jin-Jian, et al.
Publicado: (2012)

Exploring DNA Topoisomerase I Ligand Space in Search of Novel Anticancer Agents
por: Drwal, Malgorzata N., et al.
Publicado: (2011)

On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
por: Wu, Chyuan-Chuan, et al.
Publicado: (2013)

A Mini Review of Novel Topoisomerase II Inhibitors as Future Anticancer Agents
por: Okoro, Cosmas O., et al.
Publicado: (2023)

Inhibitors in AKTion: ATP-competitive vs allosteric
por: Lazaro, Glorianne, et al.
Publicado: (2020)

Invasive aspergillosis in an immunocompetent patient with fever and a cardiac mass
por: LaBarbera, Matthew, et al.
Publicado: (2011)

The ancestral role of ATP hydrolysis in type II topoisomerases: prevention of DNA double-strand breaks
por: Bates, Andrew D., et al.
Publicado: (2011)

Interaction of the Anticancer Plant Alkaloid Sanguinarine with Bovine Serum Albumin
por: Hossain, Maidul, et al.
Publicado: (2011)

The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison
por: Cowell, Ian G., et al.
Publicado: (2019)

ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways
por: Singh, Surendra, et al.
Publicado: (2015)

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy
por: Xu, Yang, et al.
Publicado: (2015)

Enhanced Stability and Bioactivity of Natural Anticancer Topoisomerase I Inhibitors through Cyclodextrin Complexation
por: González-Ruiz, Víctor, et al.
Publicado: (2021)

A Unique Topoisomerase II Inhibitor with Dose-Affected Anticancer Mechanisms and Less Cardiotoxicity
por: Li, Zhi-Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c2eed30e0kf2mgbpj19jf580f0